10106-41-9,
UNII-AOW1NH1RMD,
AOW1NH1RMD,
17,21-Dihydroxy-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione 21-Acetate,
[2-[(8S,10S,13S,14S,16R,17R)-17-hydroxy-10,13,16-trimethyl-3-oxo-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate,
Pregna-1,4,9(11)-triene-3,20-dione, 21-(acetyloxy)-17-hydroxy-16-methyl-, (16a)-;Pregna-1,4,9(11)-triene-3,20-dione, 21-(acetyloxy)-17-hydroxy-16-methyl-, (16a)-,
(16|A)-17-hydroxy-16-methyl-3,20-dioxopregna-1,4,9(11)-trien-21-yl acetate,
9,11-Dehydrodexamethasone acetate,
Pregnatriene acetate,
EINECS 233-290-4,
AC1L3AO7,
AC1Q62LT,
17-alpha,21-Dihydroxy-16-alpha-methylpregna-1,4,9(11)-triene-3,20-dione 21-acetate,
SCHEMBL5708043,
ZINC4080957,
SC-21697,
17-alpha,21-Dihydroxy-16-alpha-methylpregna-1,4,9(,
17,21-Dihydroxy-16|A-methylpregna-1,4,9(11)-triene-3,20-dione 21-Acetate,
17-Hydroxy-16alpha-methyl-3,20-dioxopregna-1,4,9(11)-trien-21-yl Acetate,
Vamorolone acetate,
VBP-15,
KST-1A0346,
C24H30O5,
AR-1A0557,
CID112077,
ZINC04080957,
C24-H30-O5,
10147-70-3,